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Abstract: Root-knot nematodes (RKN), from the Meloidogyne genus, have a worldwide distribution
and cause severe economic damage to many life-sustaining crops. Because of their lack of specificity
and danger to the environment, most chemical nematicides have been banned from use. Thus, there is
a great need for new and safe compounds to control RKN. Such research involves identifying
beforehand the nematode proteins essential to the invasion. Since G protein-coupled receptors
GPCRs are the target of a large number of drugs, we have focused our research on the identification
of putative nematode GPCRs such as those capable of controlling the movement of the parasite
towards (or within) its host. A datamining procedure applied to the genome of Meloidogyne incognita
allowed us to identify a GPCR, belonging to the neuropeptide GPCR family that can serve as a target
to carry out a virtual screening campaign. We reconstructed a 3D model of this receptor by homology
modeling and validated it through extensive molecular dynamics simulations. This model was used
for large scale molecular dockings which produced a filtered limited set of putative antagonists for
this GPCR. Preliminary experiments using these selected molecules allowed the identification of an
active compound, namely C260-2124, from the ChemDiv provider, which can serve as a starting point
for further investigations.
Keywords: Meloidogyne incognita; homology modelling; molecular dynamics; virtual screening
1. Introduction
Root-knot nematodes (RKNs) seriously threaten global food production: these microscopic,
soil-dwelling worms are highly destructive and cause up to 100% yield loss in important life-sustaining
crops like soybean, rice, cotton, tomato, etc. [1–3]. Their destructive capacities are due to their ability to
infect roots and cause galls (swellings or knots) in their host plants. The nematodes feed and develop
in the galls, in the process impeding nutrient and water uptake by the host plant resulting in poor
growth and crop yield. Additionally, such damages increase the severity of opportunistic infections by
other soil pathogens [4].
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Conventional control methods, including crop rotation, use of resistant cultivars and biological
control have limited efficacy or are not available against RKNs that have a wide host range [5].
Traditionally, RKN management relied heavily on carbamates, organophosphates and fumigant
nematicides. Due to environmental, health and safety concerns, the most efficient chemicals to
control nematodes are no longer used and are now being withdrawn [6]. As such, there is an urgent
need for safer and sustainable solutions to control RKNs. Currently, several development trials
are being undertaken around the world to find and develop eco-friendly nematicides [7,8]. On this
line of research, several new compounds are proposed but their environmental safety remains to be
validated [9,10].
In recent years, and since the availability of several nematodes genomes [11], bioinformatics
analyses have provided the basis to explore specific ways to control RKNs invasion by targeting
specific genes implied in plant parasitism [12]. A promising approach would consist in interfering
specifically with the olfactory perception of plant chemicals that attract nematodes, or with their
developmental cycle into the host plant [13–15]. These strategies would enable protection of the
plants against infection by root-knot nematodes without altering other environmental characteristics.
From a scientific point of view, such researches provides new insights towards linking molecular
methods with biochemical processes for plant protection against RKNs.
In the rice RKN (Meloidogyne graminicola), the disruption of neuropeptides involving G
protein-coupled receptors (GPCRs) signalling disturbs both behavior and migration abilities
infection [16]. This recent discovery offers a promising possibility to control the behavior of this
parasite as well as other RKN such as Meloidogyne incognita which is amongst the most devastating
plant parasite worldwide [17]. As GPCRs are recognized as an important target family for many
pharmaceutical developments [18], we prioritized the identification and classification of GPCRs
from M. incognita in order to help control this agricultural pest. GPCRs constitute a superfamily of
transmembrane proteins acting as receptors that sense molecules and trigger transduction pathways
in cells. Their 3D structure is highly conserved in opposition to their amino acid sequences that
are poorly conserved. Most GPCRs have are 200–1000 amino acids long, show a 7 transmembrane
helices structure and several additional domains related to their functional specificity and useful for
their classification.
In this paper, we mined the ensemble of predicted proteins of the RKN M. incognita to identify
putative GPCRs and select the most likely to interfere with the parasite life cycle. We then built a 3D
model of this receptor to perform a receptor-based in silico virtual screening for identification of
chemical compounds able to interfere specifically with this GPCR. Finally, we validated the activity
of the compounds through preliminary tests in vivo in order to establish the proof-of-concept to
our strategy.
2. Results
2.1. GPCR Identification and Selection
From the 43,718 predicted proteins of M. incognita 19,434 had a length between 250 and
1000 residues (Figure 1). Next, we retained only those with seven predicted transmembrane helices.
The 336 selected proteins were finally submitted to GPCRpipe in order to predict putative GPCRs.
As a result, 117 proteins can be considered as putative GPCRs in M. incognita. In order to validate our
procedure, we checked that the only protein found in UniProt described as a “GPCR” in M. incognita,
namely Q2TGX5, was in the list of the 117 proposed GPCRs.
To select among these 117 putative GPCR, the most suitable ones for our drug design campaign,
we mined the literature and all protein sequence databases to obtain additional information about
putative nematode GPCRs. From this search, some important information was collected, especially
concerning nematode chemosensory system [19] and neuropeptides GPCRs [20]. For instance,
the mechanosensory role described in FMRFamide-like peptides family in several nematodes
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were particularly interesting [16,21–26] and this peptide family is also present in M. incognita [27].
The GPCRs associated to these peptides, such as the C. elegans flp-32 receptor [28] (uniprot G5EEB1)
and FRPR-4 receptor [29] (uniprot A0A131MCZ4), have been shown to be involved in the regulation
of sexual and locomotion behaviour of nematodes and are therefore interesting targets for inhibiting
nematodes parasitism on plants. In this respect, NPR-1 receptor from C. elegans [30,31] (UniProt Q18534)
and NPR-4 receptor from C. elegans and Brugia malayi [32] (Uniprot A0A078BS36 and A0A0J9XSQ0
respectively) were interesting targets for our purpose because the proteins were annotated as
neuropeptide receptors. Consequently, we looked for their homologs among the 117 M. incognita
putative GPCRs. Three proteins, Minc3s00126g05377, Minc3s01812g26474 and Minc3s00007g00462
respectively were found as NRP homologs from sequence analysis, but only the two proteins,
Minc3s01812g26474 and Minc3s00007g00462 were annotated as “neuropeptide Y like GPCR” by
InterProScan. The whole selection process is summarized in Figure 1.
Figure 1. G protein-coupled receptors (GPCRs) selection procedure.
2.2. Homology Modelling
The first step in homology modelling is to identify the most suitable templates to use to build
the query 3D model. In our case, the best template should be a GPCR structure having sequence
similarities with our query and belonging to the same GPCR category. In order to decide which one of
the three possible GPCRs found above would be retained for performing the homology modelling
step, we performed a phylogenetic analysis with several GPRCs with available 3D structures and
others belonging to the neuropeptide receptors family. According to the phylogenetic tree obtained
(Figure 2) it appeared that the protein Minc3s00007g00462 was the closest one to the C. elegans
NPR-1 neuropeptide receptor (UniProt ID Q18534) and to the human neuropeptide Y Y1 receptor
(UniProt ID P25929) corresponding to the PDB structure 5ZBH [33], while Minc3s00126g05377 and
Minc3s01812g26474 were more related to the NRP-4 family.
Consequently, we selected the PDB template 5ZBH to build the 3D model of Minc3s00007g00462
and the two proteins sequences were aligned according to their similarities and the position of their
transmembrane helices (Figure 3).
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Figure 2. Phylogenetic tree obtained showing the proximity of Minc3s00126g05377 (green rectangle),
Minc3s01812g26474 (green) and Minc3s00007g00462 (blue) with several GPCRs and especially with the
neuropeptide Y Y1 receptor (red) for which a 3D structure was recently available in the PDB database.
Branches with support value lower than 50 were colapsed.
Figure 3. sequence alignment used for the homology modelling: alignment between Minc3s00007g
00462 (NEMATO) and the human neuropeptide Y Y1 receptor (PDB structure 5ZBH [33]). Identical
residues are in green, similar residues are in blue and the helices sequences in black rectangles.
2.3. Molecular Dynamics Simulations
The 3D model of Minc3s00007g00462 is presented in Figure 4. Concerning the 3D model
conformational behaviour, the main focus was firstly the seven transmembrane helices: if one of
them broke permanently, the model was not considered as stable and a new model had to be built
from a new alignment. During the first 10 ns, all helices were stables. The MD simulations were
prolonged to 100 ns and all helices remained stable except for the second helix which broke and
reformed itself frequently (Figure 5). This deformation can be explained by the presence of two prolyl
residues at position 91 and 94 that destabilized the helix. As the helix frequently reformed itself during
the simulation, we considered the model as stable during the MD simulations.
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Figure 4. Appearance of the initial Model 3. The red colour indicates the GPCR, the olive green colour
indicates the membrane lipids, chloride counterions are represented in orange and the grey colour
indicates the water box.
Figure 5. Evolution of the secondary structure during the 100 ns Molecular Dynamics (MD) (blue:
α-helices, yellow: β-sheets, green: 310 helices, gray: turns, white: coils).
When observing the variation of the RMSD of the GPCR backbone during the MD (taking the
first frame as the reference), the largest values (up to 8 Å) came from the loops connecting the TM
helices (especially the ones which should be intracytoplasmic). In contrast, the TM7 helix bundle and
the small β-sheet found in the large loop connecting TM4 and TM5 remained stable (maximum RMSD
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of 2.5 Å and 0.8 Å respectively). The behaviour of the receptor indicated that the model was robust
enough to be used later for our virtual screening campaign.
2.4. Selection of the Conformational Ensemble for the VS Campaign
From the 200 ns MD simulations, according to the RMSD analysis, it appeared that the molecular
system adopted five families of stable conformations (Figure 6a), c1 to c5, respectively around 24 ns,
68 ns, 130 ns, 170 ns and 190 ns. This analysis was supported by the SOM clustering as shown on
Figure 6. By considering only the 5 most dense clusters obtained after SOM, these SOM clusters
present similar sizes and fit well in the regions delimitated by the RMSD map. The alignment of the
3D structures representing each of the five families are presented in Figure 6b. The RMSD between the
five groups were always between 1.8–4.8 Å.
Figure 6. ((a), top) RMSD map. The five retained conformation families are represented in white;
((a), down) The top five Self Organizing Maps (SOM) clusters containing the largest number of frames
(represented in green) are superimposed on the RMSD map. (b) Structural alignment with a 3D cartoon
representation of the five selected protein conformations retained to perform the docking campaign
(blue 24 ns, red 68 ns, grey 130 ns, orange 170 ns, yellow 190 ns).
The observation of the binding pockets for each of these conformers revealed that all the
pocket shapes differ due to different side chains orientation of the residues lining the binding site
despite roughly similar values obtained for their volumes (around 2000–2500 Å3) and surface areas
(around 1200–1300 Å2) (Figure 7). This would have consequences on the docking results and such
a situation highlight the interest of using an ensemble docking program such as GOLD.
2.5. Virtual Screening Campaign and Compounds Selection
From the docking campaign using these five main protein conformers, we retained the top
100 molecules from the complete PLP score list for further analysis. From this list, it appeared that
85 compounds came from the ChemDiv provider’s library. Hence, for consistency, we kept only these
85 compounds in the rest of our analysis.
After inspection of molecular weights, solubility (we discarded all compounds with a logP > 5.00),
compound similarities and toxicity, 13 molecules were finally selected (Table 1). For example,
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compounds with docking scores ranked 1 to 9 and 11 to 14 had bad solubility scores >5.00 and
were removed. Consequently, the first high-scoring molecule retained was ranked only 10 in the top
100 list.
Figure 7. Shape and position of the binding pockets obtained for the 5 MD conformers retained for the
ensemble docking with the 3V web server [34].
Table 1. Molecules tested in bioassays with nematodes.
Compound ID MolWeight logP Rank
5655-0305 481.56 1.38 18
K284-4256 557.63 2.37 28
C260-2124 552.59 3.13 69
V004-4329 573.66 3.43 23
C260-2328 617.67 3.7 97
K305-0260 543.65 3.8 42
C336-0157 596.71 3.87 20
C260-2785 578.03 4.07 83
K284-3806 574.66 4.27 15
C519-2044 550.08 4.43 27
C260-1269 593.73 4.45 10
K284-4165 680.63 4.52 17
K284-4789 562.74 4.79 12
A dendrogram representing the chemical relationship between the 13 retained compounds is
presented in Figure 8 and the molecular formula of these molecules are shown in Figure 9. It is seen
from this dendrogram that the retained compounds could be roughly classified into two groups,
each presenting two subgroups.
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Figure 8. Dendrogram showing the clustering of the 13 retained molecules. The dendrogram was built
with Ward’s method using Tanimoto scores.
Figure 9. Molecular formula of the 13 selected molecules.
Looking at the interactions of these 13 compounds within the protein binding pocket, 12 retained
ligands are found mostly bound to the c3 or the c2 conformations (9/13 and 3/13 respectively).
The only exception was the C260-2124 compound that gives its highest score when bound to the
c5 protein conformation. Considering hydrogen binding interactions, a large variety of binding
possibilities were found, but the only residues that bind the majority of retained compound through
H-bonds (or -stacking) are Trp102 and Arg285. All other interactions were specific to one or two ligands.
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We illustrate in Figure 10 the ligand-receptor interaction differences between the 5655-0305 compound
as bound to the c3 conformation, the K284-3806 compound bound to the c2 conformation and the
C260-2124 compound bound to the c5 conformation.
Figure 10. LigPlot showing the diversity of protein/ligand interactions between 3 retained compounds,
respectively bound to c2, c3 and c5 protein conformations. The black circle corresponds to
pi-pi interactions.
2.6. Bioassay
The 13 candidate molecules, retained from the virtual screening list above, were tested in
nematode assays. Direct exposure of nematode infective juveniles (J2s) to the selected compounds
at 1% did not affect their viability. Nevertheless, in preliminary qualitative tests in pluronic medium
(supp figs), the observed RKNs movements seem to be altered, probably because of the drug interaction
with the predicted nematode chemosensor receptor target. Even if reduction effects on the penetration
of J2s in plant roots were observed with several compounds, reliable and consistent results of treated
nematodes were only obtained with the C260-2124 compound in three independent experiments
(Figure 11). We observed a reduction of 40 to 60% in nematode penetration in tomato roots when
nematodes were treated with the C260-2124 compound as compared to DMSO controls. This result
indicates no interference of the drugs’ solvent DMSO in the control assay.
Figure 11. Number of M. incognita larvae in tomato roots inoculated with DMSO- treated J2s (control)
or C260-2124-treated J2s in three independent experiments. Bars indicate mean number of nematodes
per plant (n = 30) and error bars indicate the standard error (SE) of the mean. Penetration was recorded
after 3 days.
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3. Discussion
Searches for novel nematicides have been tackled starting mostly from profiled peptides belonging
to the FMRF-amide or to the neuropeptide families. FMRF-amide like peptides represent the most
widely investigated family. They are characterized by -RFamide motif and are known to be involved in
motor and sensory function coordination with effects on nematodes infectivity [16]. The neuropeptide
related compounds are known to dysregulate the normal behaviour of penetration while little is known
about their function in nematodes. Nevertheless, recent studies concerning such neuropeptides-like
proved to dysregulate key behaviours [24], especially in M. incognita [35]. The most active of such
peptides has the AFDSFGTPGFTGFD sequence therefore presenting four aromatic side chains so that
it is interesting to compare the docking result of this peptide in our M. incognita GPCR models with
the one obtained for our C260-2124 compound. Such comparison is shown in Figure 12a where the
two compounds share the same part of space inside the 7TM helices binding pocket and with similar
interactions, especially H-bonds and stacking (Figures 10 and 12b). Besides the two Arg285 and Trp102
residues already implied in the interactions with our 13 selected compounds, several other residues
where found interacting with both the AFDSFGTPGFTGFD peptide and the C260-2124 compound,
such as Cys190 from its backbone carbonyl and Trp32 through pi stacking of its indole ring with
aromatic moieties of the ligands. This result reinforces the idea that C260-2124 can be considered as
a valuable hit for further investigation to lead drug design studies.
Figure 12. (a) Respective molecular surfaces of the NLP15 peptide (in orange) and our active C260-2124
compound (in green) inside the binding pockets lining the TM7 bundles of the nematode GPCR in the
c3 and c5 conformations respectively (in transparencies with corresponding colours with the ligands);
(b) Ligplot diagrams showing the interactions between the peptide compound and the nematode
GPCR. TRp102 is implied in pi stacking interactions, and Arg285 is engaged in H-bonds. Black circles
represent pi stacking interactions.
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Apart from peptide-related compounds, few small molecular weight organic compounds were
also reported in the literature. Besides BIBP-3226, which was the first selective neuropeptide
Y1 receptor (NPY Y1R) antagonist found in 1996 [36]. Some of the proposed compounds were
based on: benzazapine nuclei [37], phenoxyquinlines [38], substituted alkoxy-aminopyridine
groups [39], pyrazolo-pyrimidines fragments [40] and pyridinedicarboxylic acid derivatives such as
BMS-193885 [41], on carbamoylation of argininamide moities such as UR-MK299 [42]. Recently, the two
last antagonists, namely UR-MK299 and BMS-193885 were used in the X-ray study presenting the 3D
structure of the NPY Y1R in complex with these molecules. Figure 13 lists and presents the chemical
formulas of these compounds.
Figure 13. Low molecular weight organic compounds antagonists to NPY Y1R that were evaluated
with the GOLD docking procedure hereby described.
Docking of all these compounds according to a process similar to the one followed in our virtual
screening shows that only the UR-MK299 compound gave a score in the range of the ones obtained
with our 13 selected molecules. When looking at the interactions stabilizing this ligand, it appears
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that, besides several H-bonds implying the backbone of Glu192 and Cys109, as well as the sidechain
of Gln116, the two residues Arg285 and Trp102 found as stabilizing all our 13 compounds through
H-bonds or pi-stacking, are also engaged in similar interactions. Such result highlights the role of these
two last residues in the recognition of antagonist compounds.
Because we used the human neuropeptide Y Y1 receptor (NPY Y1R) as a template, the question
of the specificity of the compounds identified in our study to the nematode and their possible side
effects must be considered. To check that, it is interesting to compare the protein/ligand binding
characteristics found in the Y Y1 neuropeptide receptor template versus our model. When looking at
the ligands chemical structures and binding properties found in the 5ZBH and 5ZBQ PDB structures
and comparing them to the 13 proposed compounds from our virtual screening, it appeared that:
• The binding cavity obtained for our nematode GPRC receptor presented a quite similar 3D shape
when compared to the ones obtained for the two 5ZBH and 5ZBQ X-ray structures (Figure 14):
calculated cavity surface area and cavity volume of 913 Å2 and 1572 Å3, in the range of the ones
obtained for the two X-rays: 1067 and 870 Å2 respectively and 1806 and 1352 Å3 respectively;
• The two inhibitors (UR-MK299 and BMS-193885 respectively) complexed to the neuropeptide Y
Y1 receptor have very different chemical structures when compared to our selected compounds
with Tanimoto coefficients less than 0.3;
• In our model most of the 13 compounds interact through H-bonds with Arg285 (which is not
conserved in the Y Y1 receptor) and with Trp102, Gln116 and Gln173 (which are conserved
residues between the two species, corresponding respectively to Trp106, Gln120 and Gln177 in
YY1). In the Y Y1 3D structures, only interactions with Gln120 are similar to the ones found with
our compounds. Gln120 is proposed to be crucial for receptor activation as being the interaction
partner for the NPY peptide C-terminus.
• Additionally, interactions are also found in our model with residues Tyr46 and Trp102
(both conserved in Y Y1 as Tyr47 and Trp106 respectively, but none of these two residues
were found to interact with the inhibitors in the X-ray structure of YY1. Supplementary cation
interactions implying Lys100 and Arg285 (both not conserved) are also stabilizing the interactions
with some of our 13 molecules. It could be concluded from this analysis that, despite a quite
similar binding site compared to the ones in human YY1 receptor, our compounds should be very
specific to neuropeptide nematode GPCRs with few or no interactions with human neuropeptide
receptors, so that no unwanted effects can be expected.
Figure 14. Binding cavity surfaces (in red) compared to the ones obtained in the PDB 5ZBH (in green)
and 5ZBQ (in purple) within the GPCR 7-helices bundle (in gray).
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4. Materials and Methods
The in silico approach was composed of four main steps as illustrated in Figure 15 (more details
regarding the methods please see Supplementary Materials). The first step was to filter the proteomic
dataset from the nematode to identify GPCRs using several filters (sequence length selection,
transmembrane helices prediction and GPCR prediction tool. Next, the GPCRs candidates were
characterized in order to select a limited number of possible targets using sequence similarity. The third
step consisted to build a 3D model of the selected GPCR candidate and to validate it by a 100 ns
molecular dynamics simulation. The last step was to submit the GPCR candidate stable model to the
virtual screening in order to identify probable molecules to inhibit the target.
Figure 15. Data analysis framework for prediction of GPCRs. Used programs are in italics.
4.1. GPCR Identification in Nematode Genome
The initial dataset used for GPCRs prediction comprises M. incognita recent genome annotation
available V2 [43]. As the majority of GPCRs have a length between 250 and 1000 residues, the first
step of our pipeline consisted in filtering proteins within the predicted proteome according to this
range. The main GPCRs signature is their seven transmembrane helices so the retained proteins
were submitted to TMHMM [44] in order to determine their number of transmembrane helices.
Finally, GPCRpipe [45] was used on proteins with seven transmembrane helices to predict GPCRs.
GPCRpipe was configured to “and” method, meaning that a protein was predicted as a candidate if
GPCRpipe HMM and Pfam 3915 profile HMM predicted it as a GPCR. GPCR class was predicted with
InterProScan [46].
4.2. Homology 3D Model Building
Although automatic methods for GPCR homology modelling were recently developed [47,48],
the construction and validation of the various homology models of GPCRs is still a challenge [49]
and requires not only the classical multiple sequence alignments but would also include
structure-based alignments. This approach has been proved successful in many studies [50,51].
Nowadays, the structure of 20 different Class A, two Class B, two Class C, and one frizzled GPCRs are
available in the PDB [52], providing a reasonable set of possible templates to be used.
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For the template choice, selected GPCRs were aligned by PSI/TM-Coffee [53] with PDB
GPCRs. The phylogenetic analysis was done with phylogeny.fr web service [54]. After alignment,
ambiguous regions (i.e., containing gaps and/or poorly aligned) were removed with Gblocks [55].
The phylogenetic tree was built using the maximum likelihood method implemented in the PhyML
program [56,57]. Reliability for internal branch was assessed using the aLRT test (SH-Like). Graphical
representation and edition of the phylogenetic tree were performed with iTOL webserver [58].
To build the model, the selected protein and the template were aligned with AlignMe [59],
a dedicated program for membrane protein alignment, taking into account sequence properties and
secondary structure predictions. The model was built with MODELLER with the automatic loop
refinement method [60].
4.3. Molecular Dynamics
The next steps using Molecular Dynamics (MD) simulations were required to refine the
preliminary crude model and then analyse the stability of the GPCR within the membrane. For that,
we used the NAMD molecular dynamics software [61]. MD is now commonly used to validate
homology models, especially in the GPCRs field [62–65].
For this purpose, we used molecular dynamics simulation on the receptor homology models that
were embedded in a fully hydrated POPC bilayer [66]. No ligand was positioned within the receptor
at this level as it has been shown [67] that the presence of a ligand does not change the accuracy
of the structure produced. Initially, the receptors models were positioned across the equilibrated
bilayer while seeking to match the hydrophobic protein segments with the layer formed by the lipid
hydrocarbon tails. Lipids overlapping with the protein complex were deleted, leaving a bilayer
consisting of 584 POPC molecules. To ascertain that the cytoplasmic and extracellular loops did not
interact, an amount of 79,089 water molecules was added, as well as 16 chloride counter ions to make
the whole system-neutral, thus making a total number of atoms equal to 328,547. The complete system,
represented in Figure 4 was replicated periodically in the three directions of space, with a repeat
distance of ≈130 Å.
The MD simulations were carried out in the isobaric-isothermal ensemble, maintaining the
pressure and the temperature of 1.0 atm and 300.0 K, respectively, using Langevin dynamics and
the Langevin piston approach. The MD program NAMD was employed in conjunction with the
CHARMM27 force field [68] to describe the receptor, the lipid bilayer, and the water molecules.
Coulomb forces were evaluated with the particle-mesh Ewald method. The equations of motion
were integrated with a 1 fs time step, using the r-RESPA algorithm to update short- and long-range
contributions at different frequencies.
Each system was energy minimized and then equilibrated before recording trajectories. All MD
trajectory frames were recorded at 1 ps intervals, for a total of 10 ns simulation. Model stabilities were
then checked by analysing secondary structure evolution during the MD simulation. If at least one
transmembrane helix broke, then the model was not considered stable. For the stable models obtained,
the simulations were extended to reach a 100 ns simulation time.
4.4. MD Simulation Analysis
Once the MD simulations finished, all the frames were aligned on the first frame to calculate
RMSDs with VMD (“RMSD trajectory tool” plugin) [69]. An RMSD map was built by a previously
developed in-house TCL script.
In addition to the RMSD map, the trajectory obtained after molecular dynamics was analyzed by
the Self Organizing Maps (SOM) method [70]. The method consisted in transforming the coordinates
of each frame using a Principal Component Analysis (PCA) and superimposing them on a neural
network used to separate the frames [71]. Similar frames were found in the same cluster. To validated
this classification, the SOM method was repeated 30 times and Rand index was calculated for each run.
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The HGPA (Hyper-graph partitioning algorithm) cluster aggregation method is used to converge to
a consensus [72] between these clustering steps.
4.5. Virtual Screening
The initial dataset of chemical libraries were the GPCR-centred libraries encompassing six
compounds providers: Asinex [73], Chembridge [74], ChemDiv [75], LifeChemicals [76], Otava [77]
and Selleckchem [78], representing 112,951 molecules. The 3D structures of all the molecules were
obtained from the Corina software [79]. The compound protonation states and atom names were
corrected if needed, respectively, for pH 7 and compatibility with the GOLD program.
The docking was performed by GOLD which has been recognised as one of the best docking
softwares [80,81]. As several stable conformational families were identified, the ensemble of docking
possibilities was used. The use of such conformational ensembles was considered as an improved
strategy in structure-based docking calculation [82]. For each docking, 50 starting ligand conformers
were used in GOLD. All target conformations were aligned on a common reference system and
the centre of the binding pocket as an average of the individual centres determined by LigSitecsc in
each conformation [83]. The binding region was defined as a 15Å radius sphere around this centre.
Each docking was evaluated by the piecewise linear potential (PLP) scoring function for protein-ligand
docking [84,85].
In order to avoid possible toxicity, the candidate compounds were surveyed using predictors
such as PAINS-remover [86] and ProTox web service [87]. The structural similarity of the selected
compounds was evaluated by the Tanimoto index [88,89]. The score was calculated by Open
Babel using FP2 fingerprint [90]. These similarities were represented as a dendrogramm created by
hierarchical clustering with Ward’s aggregation method. For the retained compounds, protein-ligand
interactions were detected by PLIP [91].
4.6. In Vivo Experiments
As it was not presently possible to perform in vitro tests to directly measure the binding of
our selected compounds to the GPCR receptor, we will present here only very preliminary in vivo
experiments. Robust protocols for in vivo testing of products acting on root-knot nematodes are difficult
to handle and are time consuming. Valuable experiments are not as easy as for other systems because
of the particular surrounding conditions necessary for establishing nematode growth. Furthermore,
as an obligatory endo-parasite of plant roots, the only life stage that can be used for testing attack
inhibition is the infective juvenile stage [92].
4.6.1. Nematode Culture Preparation
Meloidogyne incognita was obtained from pure cultures maintained in roots of tomato plants
(Solanum lycopersicom, var. Santa Cruz Kada)). Tomato seeds were surface sterilized with 1.4% NaOCl
for 5 min followed by 2 × 15 min rinse in sterile water. After 7-days germination in Germitest paper,
tomato seedlings were transferred to a plastic pot filled with a sand/hydrogel mixture (3 seedlings
in 5-mL substrate per pot). To perform the mobility test nematode second-stage juveniles (J2) were
obtained from M. incognita egg masses extracted from previously infected plants. After approximately
two reproductive cycles, the nematode eggs were bulk extracted from severely infected tomato roots
with 0.05% (v/v) sodium hypochlorite (NaOCl) as previously described [93]. The J2 were subsequently
washed with distilled water and left for hatching in sterile water for 3–5 days at 25 ◦C using the
Baermann funnel method [94]. Freshly hatched J2s were counted and used for all bioassays.
4.6.2. Compounds Preparation
Compounds (2–5 mg each) were suspended in DMSO solution to reach a 10 mg mL−1 concentration.
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4.6.3. Bioassays
Tomato roots were inoculated with M. incognita J2s previously treated in vitro (eppendorf) with
each selected compound diluted to 1% with distilled water (v/v stock compound). Worms treated with
DMSO 1% were used as control. To verify the inoculum viability after 24 and 48 h of exposure direct
exposure to the diluted compounds, the J2’s motility was observed over a microscope slide under
visible light (Leica). The in vivo validation of the selected compounds was performed by measuring the
nematode ability to penetrate tomato roots when treated with the compounds. This ability was tested
with exposure to compounds at 1% concentration by counting the number of J2s in roots at 3 days
after inoculation (dai). A total of at least 300 freshly hatched J2 were added to each pot. The whole
experiments contained 30 replicates per treatment. The inoculated plants were cultured at room
temperature with 16h/day natural light. The M. incognita J2 penetration rate was recorded after 3 dai
by observation under a stereo-microscope (Leica) of fuchsin-stained roots [95].
5. Conclusions
The root-knot nematode M. incognita is one of the most aggressive and damaging plant-parasitic
nematodes as it uses a sophisticated chemosensory apparatus to detect potential hosts and to infect
them. Chemical nematicides have so far constituted the most efficient tools against these agricultural
pests. Because of their toxicity for the environment and danger to human health, most nematicides
have now been banned from use. Consequently, new and more specific means of control, which are
safe for the environment and human health, are urgently needed to avoid worldwide proliferation
of these devastating plant-parasites. Understanding the parasite machinery, aiming at identifying
novel targets for the development of future control methods is an important issue that concentrate
the efforts of many research groups. For that purpose, three main lines of action can be followed
dedicated respectively to the detection of the hosts by the parasite, its penetration within the host roots,
and the development of the giant cells within the roots. We focused our study on the role of GPCRs
possibly involved in the mechanism of parasite detection and locomotion towards its host’s roots.
Among all the putative GPCRs genes in the M. incognita genome, we found one GPCR belonging to
the neuropeptide receptors family that appeared as an interesting target against M. incognita. A drug
design strategy merging in silico and experimental bioassays was successfully undertaken in order to
find new low molecular weight chemical compounds able to interfere with this GPCR.
The data obtained in the present study show that some of the tested compounds affect mostly
or only the penetration rates most probably due to muscle contraction/behavioral disruption [96,97].
These results suggest that some of these substances, although not affecting mortality, may change the
nematode behavior and its sigmosoidal crawling [96]. Among these tested compounds, C260-2124,
was found as presenting the required anti-nematode characteristics. After examination of chemical
literature and patents data, this compound is not referenced for any biological assays. Only few similar
compounds were found presenting some biological action. The two closest ones (Tanimoto index
around 0.7) are presented in Figure 16: the first one is described in PubChem (MLS00073044 and
CID 16195204) and was tested in bioassays against the protein target huntingtin (Huntington disease)
and the second compound was described in US patent 2010/0267671A1 to modulate apoptosis in cells.
Our biological assays were preliminary and further investigations now have to be performed
to definitively validate our results and investigate the specificity and safety of this compound for
non-target organisms. These preliminary studies indicates the targeting of some of the selected
compounds against the nematode neuromuscular system as previously pointed by Kumari et al. [16].
However, due to the complexity of experimental conditions, a complete molecular characterization
was not performed in this study. We report here only potential compounds that affect important
roles in the M. incognita chemoreception of environmental stimuli as one of the major sensory system.
These findings may allow further research, innovation and development. Nevertheless this work is
the first one proposing a non-peptide compound acting as an antagonist of M. incognita neuropeptide
receptor, therefore validating our design strategy. C260-2124 can be considered as a good seed to
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further develop new leads and this work demonstrated the strength of combining in silico and
experimental approaches.
Figure 16. Chemical structure of our compound C260-2124 versus the two closest molecules found and
already used in bioassays.
Moreover, all the putatively C260-2124-binding amino acid residues of Minc3s00007g00462
are conserved in the homologous sequences of the other RKN of major concern Meloidogyne hapla,
M. javanica and M. arenaria. This data suggest that C260-2124 could also be active on these others
nematode species of high economic interest.
This work participates in the efforts of the research community to identify new classes of
nematicides and we believe this approach will help to strengthen the present arsenal. Besides recent
screening approaches mostly conducted on the C. elegans nematode [98,99], our approach demonstrates
that a GPCR involved in the parasite “GPS”, guiding it towards plants roots, can also be a valuable
target for developing innovative compounds.
Supplementary Materials: The following are available online, Supplementary methods, Supplementary results,
Figure S1: Meloidogyne incognita J2 at the apical zone of the tomato root meristem, Figure S2: Meloidogyne incognita
J2 in fuchsin staining nematode in root tissue.
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